Moore Nicholas
Département de Pharmacologie, CHU de Bordeaux, Université Victor Segalen, INSERM U657 Case 36, 33076 Bordeaux Cedex, France.
J R Soc Med. 2007;100 Suppl 48:2-6. doi: 10.1177/014107680710004801s01.
Ibuprofen was the first non-aspirin non-steroidal antiinflammatory drug (NSAID) to be approved for over-the-counter (OTC) use and is widely considered to be the best tolerated drug of its class. Low-dose, OTC ibuprofen has been used for pain relief for over 30 years without any obvious major health issues. However, there is no clear differentiation between the OTC and prescription doses of ibuprofen, and their respective effects. Adverse reactions to ibuprofen appear to be dose and duration dependent, and this may be the reason for the observed tolerability of the drug at OTC doses. OTC ibuprofen is at least as effective as aspirin and more effective than paracetamol. The tolerability concerns associated with higher dose NSAIDs currently do not apply to low-dose, short-term use of ibuprofen for common pain. Ibuprofen is associated with the least risk of GI complications compared with other NSAIDs and is considered relatively benign in overdose. This review will aim to distinguish the safety of OTC or non-prescription use of ibuprofen from its prescription use.
布洛芬是首个获批可用于非处方(OTC)的非阿司匹林非甾体抗炎药(NSAID),被广泛认为是该类药物中耐受性最佳的药物。低剂量的非处方布洛芬用于缓解疼痛已有30多年,未出现任何明显的重大健康问题。然而,布洛芬的非处方剂量与处方剂量及其各自的效果之间并无明确区分。布洛芬的不良反应似乎与剂量和用药时长有关,这可能是该药物在非处方剂量下具有耐受性的原因。非处方布洛芬至少与阿司匹林一样有效,且比扑热息痛更有效。目前,与高剂量非甾体抗炎药相关的耐受性问题并不适用于低剂量、短期使用布洛芬治疗常见疼痛的情况。与其他非甾体抗炎药相比,布洛芬引发胃肠道并发症的风险最低,且过量服用时相对安全。本综述旨在区分布洛芬非处方使用与处方使用的安全性。